32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
62.01.Z - Computer programming activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,5 | 0,8 | 77,9 |
EBITDA | 0,5 | 0,9 | 1,2 | 36,8 |
Short time liabilities | 1,7 | 1,3 | 1,3 | 5,6 |
Equity capital | 1,7 | 2,2 | 3 | 35 |
Operating profit (EBIT) | 0,1 | 0,5 | 0,8 | 61,2 |
Assets | 4,1 | 4,5 | 5,2 | 16,8 |
Net profit (loss) | 0,1 | 0,5 | 0,8 | 63,3 |
Cash | 0,5 | 0,9 | 1,5 | 65,8 |
Net income from sale | 7,4 | 8,6 | 10,9 | 25,8 |
Liabilities and provisions for liabilities | 2,4 | 2,3 | 2,2 | -1 |
Working assets | 3,3 | 3,5 | 4,6 | 31 |
Depreciation | 0,4 | 0,4 | 0,4 | 5,7 |
% | % | % | p.p. | |
Profitability of capital | 4,3 | 21,4 | 25,9 | 4,5 |
Equity capital to total assets | 42,2 | 49,6 | 57,3 | 7,7 |
Gross profit margin | 1 | 5,5 | 7,8 | 2,3 |
EBITDA Margin | 7,2 | 10,3 | 11,2 | 0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 82 | 54 | 45 | -9 |
Current financial liquidity indicator | 1.4472192525863647 | 1.6289564371109009 | 2.0774435997009277 | 0,5 |
Net dept to EBITDA | -0.5922525525093079 | -0.9597529172897339 | -1.242996335029602 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane